"10.1371_journal.pone.0077296","plos one","2013-10-24T00:00:00Z","Sylvaine You; Luca Piali; Chantal Kuhn; Beat Steiner; Virginia Sauvaget; Fabrice Valette; Martine Clozel; Jean-François Bach; Lucienne Chatenoud","Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité 1013, Paris, France; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland","Conceived and designed the experiments: SY LC JFB LP. Performed the experiments: SY CK VS FV. Analyzed the data: SY CK LC. Contributed reagents/materials/analysis tools: LC LP BS MC. Wrote the paper: SY LC LP MC.","The authors have read the journal’s policy and have the following conflicts. M. Clozel is one of the founders of Actelion Pharmaceuticals Ltd, senior vice-president, chief scientific officer, head of pharmacology and preclinical development, and member of the extended Actelion executive committee. L. Piali and B. Steiner are full-time employees of Actelion Pharmaceuticals Ltd. All other authors declare that there is no duality of interest associated with this manuscript. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","10","Sylvaine You","SY",9,TRUE,4,4,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
